Novel Blood Biomarkers for a Diagnostic Workup of Acute Aortic Dissection

Anja Forrer1, Felix Schoenrath2,3, Michael Torzewski4

  • 1Institute of Clinical Chemistry, University Hospital of Zurich, University of Zurich, 8091 Zurich, Switzerland.

Insights

Researchers identified potential blood biomarkers for acute aortic dissection (AAD). Interleukin-10 (IL-10) shows promise as a rule-in biomarker, while a combination of D-dimers, hs-TnT, IL-6, and PAI1 improves diagnosis accuracy.

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Medical Diagnostics

Background:

  • Acute aortic dissection (AAD) is a life-threatening cause of chest pain, lacking specific diagnostic blood tests.
  • Differential diagnosis of acute chest pain often involves acute myocardial infarction (AMI) and pulmonary embolism (PE).

Purpose of the Study:

  • To identify novel plasma biomarkers for the diagnosis of acute aortic dissection (AAD).
  • To evaluate the diagnostic performance of identified biomarkers, individually and in combination, for AAD.

Main Methods:

  • Proseek® Multiplex assays were used to screen plasma samples from patients with AAD, AMI, PE, thoracic aortic aneurysm (TAA), and non-cardiovascular chest pain (nonCVD).
  • Top candidate biomarkers were validated using conventional immunoassays and their expression analyzed in aortic tissue.

Main Results:

  • Interleukin-10 (IL-10) demonstrated high specificity (98%) and moderate sensitivity (55%) for AAD diagnosis.
  • A panel including D-dimers, high-sensitive troponin T (hs-TnT), interleukin-6 (IL-6), and plasminogen activator inhibitor 1 (PAI1) achieved 83% sensitivity and 95% specificity for AAD detection.
  • This biomarker combination correctly classified 77% of all patient cases.

Conclusions:

  • IL-10 presents potential as a specific rule-in biomarker for AAD.
  • Combining IL-6 and PAI1 with hs-TnT and D-dimers may enhance the differentiation of AAD from other acute chest pain causes like AMI and PE.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
505
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
319
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
76
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
73
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
159
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
142